Duke Preclinical Translational Research Unit leverages the tremendous resources and advanced expertise of Duke University for our colleagues and industry partners who want to advance their research to clinic.
Our mission is to accelerate translational research via improving the reproducibility rate of preclinical trial and ultimately improve the success rate of clinical trials, and decrease the development time.
We are experts in the entire translational pathway, drug development, and medical device process and can guide your compound or technology ideas through the often complex process—choosing the most relevant animal model, determining clinical applications, navigating regulatory pathways, design the study plan and more.
Because we look at the process comprehensively, we can provide advice and assistance outside of your area of expertise and help you achieve your goals faster.
To learn more about the Duke Preclinical Translational Research Unit’s work or to get started, contact us.